fashion -WSS

fashion

author：entertainment 2025-09-06 03:53:44 - browse：42815

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Why are elite athletes different? Take a look at their microbes

entertainment

focus

WSS

Having children helps parents live longer, especially after age 80

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

3 hurdles to bringing medical devices to the U.S. market

Study gives hint on South Asians’ higher risk of cardiovascular disease

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Ebola vaccine can save some who are already sick, per new study

explore

fashion

hotspot

Bright Health sells Medicare Advantage business to Molina

What would happen to your eyes if you looked at the solar eclipse?

Drug repurposing or repositioning? The language matters

CDC concerned about possible undetected monkeypox spread in U.K.

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Tome Biosciences co

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bernie Sanders gets little from pharma CEOs on drug prices

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ACIP vaccine advisory panel sees its vacancies filled

focus

Do masks work? RCTs can't tell us

Do masks work? RCTs can't tell us

WATCH: Why do fingernails fall off when they're damaged?

The battle over the Brookhaven Landfill on Long Island

Juul documents reveal insider tactics on political lobbying

Latigo launches with $135 million for Vertex

hotspot

entertainment

focus

Wikipedia